Mahkam Zanganeh - 13 Oct 2023 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Executive Officer, Director
Signature
/s/ Mahkam Zanganeh
Issuer symbol
SMMT
Transactions as of
13 Oct 2023
Net transactions value
$0
Form type
4
Filing time
16 Oct 2023, 16:08:25 UTC
Previous filing
06 Jul 2023
Next filing
15 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +11,988,198 11,988,198 13 Oct 2023 Common Stock 11,988,198 $1.68 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 11,988,198 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.
F2 Not applicable.